[Form 4] DocuSign, Inc. Insider Trading Activity

Rhea-AI Filing Summary

DocuSign director Anna Marrs was granted equity on 08/29/2025 consisting of 729 restricted stock units (RSUs) that convert one-for-one into common shares upon vesting. The RSUs were reported with a $0 price and have a vest commencement date of May 29, 2025, vesting in equal quarterly installments over one year, with the fourth installment accelerating to the earlier of the next annual meeting or the one-year anniversary, subject to continued service. After the reported transactions, the Form 4 shows 10,802 shares of common stock beneficially owned and 2,187 RSUs outstanding for the reporting person.

Positive

• Grant disclosed: 729 RSUs reported, increasing transparency of insider compensation
• Vesting terms provided: commencement date May 29, 2025 with equal quarterly vesting and specified acceleration
• Post-transaction holdings disclosed: 10,802 common shares beneficially owned and 2,187 RSUs outstanding

Negative

• None.

Insights

Financial Analyst

TL;DR: Director received a standard-size equity grant; reported holdings remain modest relative to institutional stakes.

The Form 4 documents a non-cash grant of 729 RSUs to a director, filed under Section 16. The RSUs carry a vesting schedule beginning May 29, 2025, with quarterly vesting over one year and potential acceleration tied to the next annual meeting or one-year anniversary. The grant was reported at a $0 price consistent with typical equity awards that convert on vesting. The filing discloses 10,802 common shares beneficially owned and 2,187 RSUs outstanding post-transaction, providing transparency on insider holdings without indicating any cash purchase or sale activity.

Corporate Governance Expert

TL;DR: Grant structure and reporting appear routine and compliant with Section 16 disclosure requirements.

The disclosure shows the use of restricted stock units with a defined commencement date and a quarterly vesting cadence, including a defined acceleration clause for the fourth installment. The Form 4 is signed by an attorney-in-fact and reports both vested-equivalent and outstanding RSUs, fulfilling required reporting fields. There are no amendments indicated and no derivative exercises or dispositions reported in this filing.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Marrs Anna

(Last) (First) (Middle)

C/O DOCUSIGN, INC.

221 MAIN STREET, SUITE 800

(Street)

SAN FRANCISCO CA 94105

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
DOCUSIGN, INC. [ DOCU ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
08/29/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	08/29/2025		M		729	A	$0	10,802	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Units	(1)	08/29/2025		M			729	(2)	(3)	Common Stock	729	$0	2,187	D

Explanation of Responses:

1. Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's common stock.

2. The RSUs have a vest commencement date of May 29, 2025 and will vest in equal quarterly installments over one year, provided that the fourth quarterly installment shall vest in full on the earlier of (i) the date of the Company's next annual meeting of stockholders and (ii) the one year anniversary of the grant, in each case, subject to the Reporting Person being a service provider through each such date.

3. The RSUs do not expire; they either vest or are canceled prior to vesting date.

Remarks:

	/s/ Derrick Chapman, Attorney-in-fact	09/02/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Anna Marrs report on the Form 4 for DOCU?

The Form 4 reports a grant of 729 restricted stock units (RSUs) on 08/29/2025 and shows 10,802 common shares beneficially owned after the transaction.

What are the vesting terms for the RSUs reported by DOCU director Anna Marrs?

The RSUs have a vest commencement date of May 29, 2025 and vest in equal quarterly installments over one year, with the fourth installment accelerating to the earlier of the next annual meeting or the one-year anniversary, subject to continued service.

Was there any cash paid for the RSUs in the Form 4 filing?

No cash was reported; the RSUs are listed with a $0 price and are contingent rights to receive common stock upon vesting.

How many RSUs and shares remain outstanding for the reporting person after the transaction?

The filing shows 2,187 RSUs outstanding and 10,802 common shares beneficially owned following the reported transactions.

Did the Form 4 indicate any exercises, sales, or dispositions by the reporting person?

No exercises, sales, or dispositions were reported; the transaction code is M indicating a grant of awards, and all reported entries are acquisitions of RSUs or contingent rights.